| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -38% |
| 3Y CAGR | -36% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -53% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,955.00 -23.20 (0.47%) | 22,759.95 | 30.96 | 5.42 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,490.00 -70.80 (2.76%) | 19,444.55 | 28.68 | 5.42 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,449.50 +34.00 (0.46%) | 18,526.25 | 109.22 | 21.23 | ||
Natco PharmaNATCOPHARM | ₹880.25 -2.15 (0.24%) | 15,806.45 | 13.81 | 1.71 |